Sagent Pharmaceuticals Announces Closing of 5.75M Share IPO
Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT) today announced that it has closed its previously announced initial public offering of 5,750,000 shares of its common stock at a price to the public of $16.00 per share. In connection with the initial public offering, the underwriters exercised in full their option to purchase an additional 862,500 shares of common stock from the Company.
As a result, the total initial public offering size was 6,612,500 shares of common stock.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.